Close
  • All
  • Centres
  • Courses
  • Events
  • News
  • People
  • Projects
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Considering equity in priority setting using transmission models: Recommendations and data needs.
Quaife, M; MEDLEY, GF; JIT, M; Drake, T; Asaria, M; Van Baal, P; Baltussen, R; Bollinger, L; BOZZANI, F; BRADY, O; Broekhuizen, H; Chalkidou, K; Chi, Y-L; Dowdy, DW; Griffin, S; Haghparast-Bidgoli, H; Hallett, T; Hauck, K; Hollingsworth, TD; MCQUAID, CF; Menzies, NA; Merritt, MW; Mirelman, A; Morton, A; RUIZ, FJ; ... Gomez, GB.
2022
Epidemics, (2022).41, 10.1016/j.epidem.2022.100648.
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi.
THINDWA, D; Mwalukomo, T; Msefula, J; Jambo, K; Brown, C; Kamng'ona, A; Mwansambo, C; Ojal, J; Flasche, S; French, N; Heyderman, R; Swarthout, T;
2022
medRxiv (2022). 10.1101/2022.05.12.22274986.
Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study.
Portnoy, A; Hsieh, YL; ABBAS, K; KLEPAC, P; Santos, H; Brenzel, L; JIT, M; Ferrari, M;
2022
BMC Medicine, (2022).20 1 10.1186/s12916-022-02242-2.
An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy.
PERTWEE, E; Simas, C; LARSON, HJ;
2022
Nature medicine, (2022).28 3 10.1038/s41591-022-01728-z.
The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design.
Benest, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
Vaccines, (2022).10 11 10.3390/vaccines10111838.
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
PARKER, EP K; Desai, S; Marti, M; Nohynek, H; Kaslow, DC; Kochhar, S; O'Brien, KL; Hombach, J; WILDER-SMITH, A;
2022
The Lancet Global Health, (2022).10 3 10.1016/S2214-109X(21)00593-3.
Vaccines and the social amplification of risk.
LARSON, HJ; LIN, L; Goble, R;
2022
Risk Analysis, (2022).42 7 10.1111/risa.13942.
Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis.
LIU, Y; PEARSON, CA B; Sandmann, FG; BARNARD, RC; Kim, J-H; CMMID COVID-19 Working Group,; FLASCHE, S; JIT, M; ABBAS, K;
2022
The Lancet Regional Health - Europe, (2022).17, 10.1016/j.lanepe.2022.100381.
The impact of local vaccine coverage and recent incidence on measles transmission in France between 2009 and 2018.
ROBERT, A; KUCHARSKI, AJ; FUNK, S;
2022
BMC Medicine, (2022).20 1 10.1186/s12916-022-02277-5.
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low- and middle-income countries.
Portnoy, A; Clark, R; WEERASURIYA, C; Mukandavire, C; Quaife, M; Bakker, R; Garcia Baena, I; Gebreselassie, N; Zignol, M; JIT, M; WHITE, R; Menzies, N;
2022
medRxiv (2022). 10.1101/2022.10.29.22281678.